Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Share-based Compensation (2016 - 2025)

Rockwell Medical's Share-based Compensation history spans 16 years, with the latest figure at $457000.0 for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 19.63% year-over-year to $457000.0; the TTM value through Dec 2025 reached $1.8 million, up 40.56%, while the annual FY2025 figure was $1.8 million, 40.56% up from the prior year.
  • Share-based Compensation reached $457000.0 in Q4 2025 per RMTI's latest filing, down from $532000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $532000.0 in Q3 2025 to a low of -$236000.0 in Q1 2021.
  • Average Share-based Compensation over 5 years is $264900.0, with a median of $315000.0 recorded in 2023.
  • Peak YoY movement for Share-based Compensation: tumbled 125.24% in 2021, then skyrocketed 218.56% in 2023.
  • A 5-year view of Share-based Compensation shows it stood at $385000.0 in 2021, then crashed by 42.86% to $220000.0 in 2022, then decreased by 0.91% to $218000.0 in 2023, then soared by 75.23% to $382000.0 in 2024, then grew by 19.63% to $457000.0 in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Share-based Compensation are $457000.0 (Q4 2025), $532000.0 (Q3 2025), and $382000.0 (Q2 2025).